NX Group and JAL Launch Intra-Asia/North America-Asia Transport Partnership

- Building Transport Network with Large Freighter Aircraft to Meet Growing Demand for AI- and Semiconductor-related Cargo Transportation -

TOKYO, Oct. 7, 2026 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. ("NX Group") and Japan Airlines Co., Ltd. ("JAL") have launched a transport partnership covering intra-Asia and North America-Asia routes, utilizing a Boeing 747 freighter ("747F") secured by JAL through cooperation with its partners. The service operates on a round-trip circuit originating in Los Angeles and routing via Narita, Taipei (Taoyuan), Singapore and Narita before returning to Los Angeles, responding to robust demand between North America and Asia as well as within Asia. The first flight departed Los Angeles on Saturday, October 3, 2026. The service is available with one flight per week in 2026, and both companies will continue to pursue further network expansion going forward.

Logo: https://drive.google.com/file/d/1dqm0cxpYamnvMUra1AGXMuGlX932Z353/view?usp=drive_link

Image1: https://drive.google.com/file/d/1R89Wm4ltRkyCoIhdG9mICMS76uZKaiem/view?usp=drive_link

Service Features

-Securing scarce large-freighter capacity within Asia

Demand for AI- and semiconductor-related cargo is currently very strong, particularly between Tokyo, Taipei and Singapore, yet few airlines operate large freighters within Asia, leaving shippers with limited options. By operating the Narita-Taipei-Singapore-Narita route with a 747F offering a maximum payload of approximately 100 tons, this service provides a distinctive, high-value-added offering that creates a vital network within Asia.

-Strengthening transport network linking North America and Asia

Because cargo can be loaded and unloaded at each port of call on the circuit route, the service enables the design of diverse transport routes and efficient transport operations, flexibly meeting cargo transport needs between North America (including Latin America beyond) and Asia.

-Meeting demand for rapidly growing high-value-added cargo

Leveraging the unique capabilities of large freighter aircraft, the service accommodates transport demand for oversized and heavy cargo such as server racks and data center-related equipment, as well as high-value-added cargo, which is increasing alongside the spread of generative AI and expanding investment in digital infrastructure.

Through this partnership, the two companies will secure stable and flexible air transport capacity, deliver optimal transport services that meet diverse needs and pursue sustainable growth as part of the logistics infrastructure.

Image2: https://drive.google.com/file/d/1tmYm1GzYQ6IGhiXI7VHqjRoOMFXNR41q/view?usp=drive_link

Comments from Representatives

NIPPON EXPRESS HOLDINGS, INC.

Satoshi Otsuji, Senior Managing Executive Officer, President of Global Business Headquarters

"Through this partnership, the NX Group will strengthen its ability to provide more stable and flexible transport solutions in response to increasingly sophisticated and diverse air transport needs. Building on our many years of cooperation with JAL, we will further expand our international air cargo network utilizing large freighter aircraft, contributing to the stability of our customers' supply chains and to their business growth."

Japan Airlines Co., Ltd.

Yuichiro Kito, Executive Officer, Senior Vice President - Cargo and Mail

"This new partnership further strengthens the long-standing relationship between JAL and the NX Group. In addition to our passenger flights and our own freighter network, this partnership with NX will bring large freighter service to the U.S. West Coast for the first time. We will expand our air cargo network in rapidly growing markets and deliver JALCARGO's high-quality cargo handling services to even more customers."

About the NX Group: 

https://drive.google.com/file/d/1mbvBL6C8THZNrR5LREgGeafNkEdaAmV-/view?usp=drive_link

NX Group official website: https://www.nipponexpress.com/

NX Group's official LinkedIn account: https://www.linkedin.com/company/nippon-express-group/

SOURCE NIPPON EXPRESS HOLDINGS, INC. and Japan Airlines Co., Ltd.

Share this article

OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration

LONDON, Oct. 7, 2026 /PRNewswire/ -- OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product's potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetration of tyrosine kinase inhibitors (TKIs).

OB-001 is a highly selective and effective inhibitor of two key efflux pumps (P-gp and BCRP), which are present both on the blood-brain barrier and on tumour cells. The product is being developed as a once-daily oral tablet, which will be used in combination with a number of gold standard oncology treatments in order to optimise their efficacy.

In perfused-brain mouse studies, OB-001 pretreatment significantly raised brain exposure of four gold standard kinase inhibitors – whilst systemic (plasma) exposure remained broadly unchanged. Data presented at AACR 2026 demonstrated that OB-001 could increase the brain exposure of osimertinib by almost 400% with minimal systemic changes[1],[2]. Based on a translational PK-PD-TGI model for osimertinib, this increase is projected to deliver a step-change in CNS progression-free survival for EGFRm NSCLC patients. The improved control of brain metastases is still a major area of unmet need in NSCLC and breast cancer.

The same efflux pumps have also been identified as a key resistance mechanism impacting ADCs – with the over-expression of these pumps leading to reduced payload concentrations in the tumour. Preclinical work using a bidirectional transporter assay demonstrated that OB-001 reduces efflux for several leading payloads, including SN-38 (e.g. sacituzumab govitecan, Trodelvy®), DM4 (e.g. mirvetuximab soravtansine, Elahere®) and DXd (e.g. trastuzumab deruxtecan, Enhertu®).

Plans are currently underway to move into a parallel clinical trial programme to generate POC data in combination with osimertinib, and also evaluate T-DXd re-sensitisation.

"This is a critical milestone for our team, and we are now well positioned to initiate our clinical plans with OB-001" said Jim Millen, Chief Executive Officer for OncoBayes. "OB-001 is on track to become a first-in-class drug with broad potential as a simple, oral adjunct to a range of blockbuster oncology therapies. This is truly a pipeline in a product opportunity."

References:

1. AACR2026 Abstract 5873. 1 April 2026; 86 (7_Supplement): 5873. https://doi.org/10.1158/1538-7445.AM2026-5873.

2. Cancer Research Communications 1 May 2026; 6 (5): 1213–1219. https://doi.org/10.1158/2767-9764.CRC-25-0553.

SOURCE OncoBayes

Share this article

Market Logic's DeepSights MCP scales market insights reach and business impact through enterprise-wide AI workflows

DeepSights MCP, now generally available, connects an expert market intelligence AI to Microsoft Copilot, ChatGPT, Claude and custom agents, so everyday AI work draws on accurate, cited market evidence

BERLIN, Oct. 7, 2026 /PRNewswire/ -- Market Logic Software, the company behind DeepSights. the leading AI market intelligence platform, today announced the general availability of DeepSights MCP. The Model Context Protocol (MCP) connection makes DeepSights the expert source that enterprise AI assistants and agents consult whenever a question depends on knowledge of the market. It extends the reach of each customer's curated market knowledge from the insights team to every employee and every AI workflow in the business.

Large organizations invest tens of millions every year in consumer and market research. The return on that investment depends on how widely, and how often, the resulting insights shape business decisions. Connecting trusted market intelligence to the rapid spread of enterprise AI assistants, from Microsoft Copilot to ChatGPT and Claude, creates a golden opportunity to extend insights impact to a new level.

Once the DeepSights MCP is in place, AI assistants call on DeepSights as a matter of course to answer questions about customers, categories and competitors. Similarly, automated, multi-step workflows proactively draw expert input on market from DeepSights before handing off to other agents to complete tasks.

The connection also addresses the growing risk of business decisions being fed by incomplete or misleading information by generic AIs rather than specialized AI. DeepSights works the way an insights expert does to provide an accurate, evidence-backed view of the market. It analyzes information proactively, separating what is relevant from noise. DeepSights works only on trusted data and cites its references in every answer.

"Your AI knows your company. DeepSights knows your market," said Olaf Lenzmann, Chief Innovation and Product Officer at Market Logic. "Our customers have spent years and significant budgets building a unique understanding of their consumers and markets. Adding DeepSights at the market intelligence layer for enterprise AI ensures that competitive advantage is seized on and integral to decision making processes. The DeepSights MCP will make it easier than ever for trusted, evidence-backed market intelligence to flow freely through the organization."

Establishing DeepSights as the trusted market intelligence layer for all AI workflows also gives insights and IT teams one central way to govern and secure the knowledge that creates their unique market understanding. Insights team continues to decide which sources are trusted. User permissions in DeepSights controlling which sources an individual has access to are carried through by the MCP into information shared through other AI assistants. Because the connection is built on the open Model Context Protocol (MCP), the same governed layer serves every assistant and agent the company adopts.

DeepSights MCP is generally available to DeepSights customers today. It works with Microsoft Copilot, ChatGPT, Claude, Glean and other assistants and agents that support the Model Context Protocol. For more information, visit www.marketlogicsoftware.com.

About Market Logic Software

Market Logic Software is a provider of pioneering market intelligence and insights solutions. Its AI-enabled platform, DeepSights, helps organizations make research and market intelligence available to decisionmakers across the enterprise at scale and speed. For more than 15 years, Market Logic has worked with consumer-focused brands around the world to support insights-driven decision-making. Customers include Vodafone, Bayer and Philips. More information is available at https://marketlogicsoftware.com.

SOURCE Market Logic Software AG

Share this article

LG CNS Showcases Pharma-Specific Manufacturing AX at World's Largest Pharma-Biotech Show

- Participates in CPHI Milan 2026, Expanding Manufacturing AX Reach in Pharma

- Showcasing key solutions for factory design, production operations, and quality management using the theme "Autonomous Factory in Pharma"

SEOUL, South Korea and MILAN, Oct. 7, 2026 /PRNewswire/ -- LG CNS, a leading AI Transformation company in Korea, is expanding its manufacturing AX business with a showcase of pharma-specific smart factory technologies at CPHI Milan 2026, the world's largest pharmaceutical and biotech exhibition.

The Convention on Pharmaceutical Ingredients (CPHI) is a global pharma and biotech trade show held at various global venues throughout the year, including the United States, Europe, Asia, and the Middle East. The Milan show is CPHI's flagship event, drawing around 60,000 visitors and roughly 3,000 companies from more than 160 countries. It is widely regarded as the premier stage on which the latest technologies and trends of the global pharma and biotech industry converge. LG CNS is the only Korean company participating in the newly created "AI & Tech" zone this year.

The theme of LG CNS's booth is Autonomous Factory in Pharma and is designed around the introduction of three smart factory solutions connecting factory design, production operations, and quality management. Pharma and biotech companies building or expanding production facilities can adopt these solutions across the entire process, from factory construction through ongoing operations.

For the factory design stage, LG CNS presents Factova Worldworks, a digital twin-based virtual validation simulator that recreates the actual factory in a virtual space. It models the factory layout in 3D to review the optimal placement of pharmaceutical manufacturing equipment, the routes that workers will take within the planned factory, and the path along which raw materials are to be transferred. Pharmaceutical factories separate zones such as cleanrooms and production areas to prevent raw material contamination. Worker access permissions also differ by zone, so planning their routes carefully in advance is more essential than in general manufacturing factories.

Factova Control is a data standardization and equipment control solution for the production operations stage. It automatically converts process data such as raw material ID numbers and formulations into a unified format, unit, and notation so that every manufacturing step works from consistent data. This lets customers respond immediately when adding new equipment or changing process workflows. The solution also detects equipment anomalies and predicts failures, using AI to analyze electrical current, temperature, and vibration data in real time to flag early warning signs.

The quality management solution analyzes data such as production volume, raw material temperature changes, and equipment operation history to check for product quality issues. It also supports everything from root-cause investigations to follow-up actions when problems are identified. Notably, when it detects an anomaly midway through a process, it immediately calculates alternatives to resolve the issue and then applies them to the next production step, proactively preventing defective products.

An AI agent trained on quality data also drafts the Annual Product Quality Review (APQR). Pharma and biotech companies conduct annual quality reviews to comply with each country's Good Manufacturing Practice (GMP) regulations and document the results in the APQR. Previously, staff collected, analyzed, and verified the required data by hand, a process that could take months. LG CNS has automated the entire process with AI, cutting the time required by more than 90%.

"The manufacturing AX solutions we are showcasing at this exhibition are tailored to pharma so we can support our pharma and biotech customers with intelligent automation across the entire process, from factory design to quality management," said Eddie Jang, Head of the Chemical/Battery Division at LG CNS. "As a turnkey provider covering every area of manufacturing, we will continue to use our advanced solutions to address the challenges of developing pharmaceutical manufacturing sites, which demand high precision and strict quality standards, and help customers produce medicines in a more automated and efficient way."

About LG CNS

LG CNS is a leading Korean AX (AI Transformation) company that continues to pioneer various emerging technologies, including AI, robotics, cloud computing, data center, and smart engineering, encompassing smart factories and smart logistics, as well as digital marketing. The company also leads the market through innovative system integration (SI) and system management (SM) capabilities across finance, manufacturing, the public sector, and various other industries. For more information, please visit https://www.lgcns.com.

Share this article

NEW DELHI, Oct. 7, 2026 /PRNewswire/ -- Fibocom showcases its MGB Series GNSS portfolio at India Mobile Congress (IMC) 2026, featuring MGB180, MGB280 and MGB390. Spanning cost-efficient single-frequency positioning to dual-frequency and RTK-enabled high-accuracy positioning, the series offers flexible options for IoT devices with different design priorities, including cost, power consumption, positioning accuracy and regional satellite compatibility.

MGB180 and MGB280 address mainstream single-frequency GNSS requirements, supporting GPS, BDS, GLONASS, Galileo and QZSS. Both integrate AGNSS and provide 96 tracking channels. MGB180 targets highly cost-sensitive tracking devices, combining compact integration with low-power operation. MGB280 further balances positioning performance and power efficiency, with strengths in fast startup, reacquisition and cellular coexistence for applications such as asset tracking, fleet management and vehicle telematics.

For more demanding positioning requirements, MGB390 extends the series with dual-frequency GNSS and 180 tracking channels. The MGB390-AR supports RTK high-accuracy positioning, with specified horizontal accuracy of 1 cm + 1 ppm. The MGB390-A supports NavIC (IRNSS), India's regional navigation satellite system, strengthening local applicability for the Indian market.

"As India's IoT ecosystem continues to grow, customers are looking for reliable technology partners that can support their journey from product development to large-scale deployment," said Kony Li, General Manager of Fibocom MTC Business Unit. "With the MGB Series, Fibocom provides flexible GNSS solutions covering different levels of cost, power consumption and positioning performance, helping local customers accelerate the development and commercialization of IoT devices."

MGB180, MGB280 and MGB390 are all in mass production. Fibocom continues to work with customers and ecosystem partners in India to accelerate product integration and commercialization across location-enabled IoT devices.

About Fibocom

Fibocom, founded in 1999, provides wireless communication and AI solutions through integrated hardware and software capabilities. Its portfolio spans cellular communication, AI, automotive and GNSS modules, supporting intelligent connectivity across industries including transportation, energy, retail and robotics.

SOURCE Fibocom

Share this article

Half-day complimentary workshop will provide Santa Barbara County nonprofit staff and board members with strategies to build media visibility and earn meaningful coverage

SANTA BARBARA, Calif., Oct. 7, 2026 /PRNewswire/ -- Marketing Maven CEO and president Lindsey Carnett will lead "Building Media Visibility For Your Nonprofit: PR Strategies That Get Results," an in-person workshop presented by California Lutheran University's Center for Nonprofit Leadership with support from the Santa Barbara Foundation on Wednesday, October 7, 2026 from 9 a.m. to noon at the Santa Barbara Foundation's South County office.

Through the generous support of the Santa Barbara Foundation, the workshop is offered free of charge to nonprofit professionals and board members serving communities throughout Santa Barbara County. The interactive, three-part workshop is designed to help participants develop the skills and strategies needed to identify newsworthy stories, craft compelling messages and build relationships with relevant media outlets.

"Every nonprofit has stories worth telling, but earning meaningful media coverage requires knowing how to identify those stories and communicate why they matter," said Carnett. "My goal is for participants to leave with practical PR strategies they can immediately put to work to strengthen visibility, build credibility and create greater awareness of their organizations and missions."

During the workshop, participants will develop potential story ideas, refine media pitches and practice identifying appropriate media targets while receiving feedback in a collaborative environment. Attendees will also learn how to repurpose earned media coverage across other marketing channels to extend its value and support broader organizational objectives.

The workshop will explore how strategic earned media can help nonprofits strengthen donor engagement, increase community awareness, support board recruitment and engagement and enhance organizational reputation. A panel of local nonprofit leaders who have successfully generated media coverage will share their experiences, practical strategies and lessons learned, providing attendees with real-world insights they can apply within their own organizations.

Carnett is a marketing and public relations professional with more than two decades of industry experience. As CEO and president of Marketing Maven, a research-driven integrated marketing and public relations agency, she has advised organizations on public relations, reputation management, social media, search engine optimization, GEO and other integrated communications strategies. Carnett also serves as a faculty lecturer for Cal Lutheran's Center for Nonprofit Leadership and is an alumna of the university.

"Building Media Visibility For Your Nonprofit: PR Strategies That Get Results" will take place Wednesday, October 7, 2026, from 9 a.m. to noon at the Santa Barbara Foundation South County office, 1111 Chapala Street, Suite 200, Santa Barbara. Additional information and registration are available through Cal Lutheran's Center for Nonprofit Leadership: Building Media Visibility For Your Nonprofit: PR Strategies That Get Results | Center for Nonprofit Leadership

To attend, please reach out to Sophia Coffaro at [email protected] or Brewster King at [email protected].

About the Center for Nonprofit Leadership

As the only management training center of its kind in the region, the Center for Nonprofit Leadership provides practical and affordable professional development opportunities for nonprofit leaders serving Ventura and Santa Barbara Counties. The CNL is committed to equipping nonprofit leaders with data-driven resources and training to support long-term success. To learn more, visit CalLutheran.edu/CNL or contact [email protected]/.

About Santa Barbara Foundation

Founded in 1928, the Santa Barbara Foundation actively connects donors, nonprofits, government, businesses and the people of Santa Barbara County to take on the most challenging needs facing our region's communities. Recognizing that its work depends on the strength of the social sector, the Foundation is committed to the health and vitality of local nonprofits. Knowing that together we can do more, the Foundation mobilizes charitable giving and connects their expertise to that of donors, nonprofits and residents to create meaningful impact on the communities of our county. SBFoundation.org.   

About Lindsey Carnett

Lindsey Carnett is a marketing and public relations professional who developed The Marketing Maven Method to simplify marketing by empowering leaders to make data-driven marketing decisions. Lindsey is the CEO of Marketing Maven, a research, digital and PR firm headquartered in Ventura County, and author of the recent book, The Marketing Maven Method: Secrets of a Maven.

A two-time honoree of Inc. 5000 Fastest Growing Independently Owned Companies in America, as well as an Entrepreneur 360 Most Entrepreneurial Companies in America award recipient, Lindsey has taken her business expertise global to enlighten marketing peers and business leaders about best practices in using PR to drive engagement, improve organic SEO, and grow a positive online reputation.

Having spoken at high profile national marketing and consumer products conferences and guest lectured at universities, Carnett has gained the reputation as an expert in the field of marketing and public relations. Her areas of specialties include: Public Relations, Social Media, Reputation Management, Direct Response Marketing, U.S. product launches, SEO, GEO, Event PR, and Spanish Media. To learn more about Lindsey, visit www.LindseyCarnett.com.

About Marketing Maven:

With offices in Camarillo, Los Angeles, and New York City, Marketing Maven is a full-service marketing and communications agency. With origins in direct response public relations, Marketing Maven has developed into a premier voice in brand strategy, social media, innovative media relations, market research, Hispanic marketing, digital advertising and search engine optimization (SEO/GEO). Marketing Maven leads the industry in utilizing advanced metrics to measure their clients' marketing reach and providing competitive analysis unparalleled in the industry. For additional information about Marketing Maven, visit http://www.MarketingMaven.com.

Contact: [email protected]

SOURCE Marketing Maven Public Relations, Inc.

Share this article

Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC

- Roche Diagnostics has provided two molecular testing instruments to Institut National de Santé Publique (INSP) to support Ebola testing capacity in the DRC.

- Roche will preconfigure the instruments and train local laboratory technicians before deploying them to Bunia.

- INSP will conduct local validation of the Bundibugyo virus, after which Roche anticipates further tests could be shipped and additional instruments deployed

JOHANNESBURG, Oct. 7, 2026 /PRNewswire/ -- As the outbreak of Ebola disease caused by Bundibugyo virus continues in the Democratic Republic of Congo (DRC), demand for testing is exceeding current available laboratory capacity, and strategic public-private partnerships are powering rapid testing and a more effective disease response. As a result, Roche Diagnostics has committed to reinforcing local laboratory testing capacity and training laboratory staff to boost essential testing capacity.1

Roche Diagnostics has provided two molecular testing instruments to the Institut National de Santé Publique (INSP), which is supporting the DRC's Ministry of Health-led Ebola response. Roche will preconfigure the Light cycler and Magna Pure instruments, and local laboratory technicians will receive training before deploying the equipment to Bunia for validation testing.

"Outbreak response depends on having the right testing capability available where it is needed," said Johan Descombes, General Manager, Francophone West Africa. "By working with the INSP to provide equipment, training and support for local validation, Roche Diagnostics is helping to expand the laboratory capacity available to the dedicated responders in the DRC. At this critical time, local expertise is crucial to fighting the outbreak, and this is an important step forward in expanding testing capacity to help respond to local needs."

The delivery follows Roche's announcement in June that it had developed a Research Use Only molecular PCR test targeting Bundibugyo virus. With the instruments now in the DRC, this partnership aims to build local testing capacity and secure the regulatory validation needed before shipping further tests.

As of 28 September 2026, UN Health Authority data reported 8,067 confirmed cases and 3,901 deaths, putting the case fatality rate at 48.4% across 60 health zones in six provinces. WHO assessed the risk in the DRC as very high and confirmed that the outbreak remains a public health emergency of international concern.

Rapid, reliable laboratory testing is vital to outbreak response, supporting case detection, surveillance, and efforts to interrupt transmission. WHO's temporary recommendations for the DRC emphasise strengthened surveillance, case detection and investigation as part of the ongoing efforts to curb the current outbreak.3

"The delivery of these instruments is an important step, but the work continues," concluded Descombes. "As validation progresses, we are committed to working alongside the INSP and local laboratory teams to understand where further support can make the greatest difference. We aim to contribute to testing capacity that can respond to this outbreak and strengthen preparedness for future outbreaks and pandemics."

Once validation of the Research Use Only tests is complete, Roche anticipates deploying additional instruments and expediting delivery of more tests to support the response.

About Roche

Roche (SIX: RO, ROP; OTCQX: RHHBY) is a healthcare company uniquely placed to prevent, stop and cure diseases by uniting leading science and technology across diagnostics, medicines and digital solutions.

Roche was founded in Basel, Switzerland in 1896 and today is a leading provider of transformative medicines and diagnostics for millions of people in over 150 countries around the world. It is dedicated to tackling healthcare challenges that place the greatest strain on patients, families, communities and healthcare systems. Across its Diagnostics and Pharmaceutical divisions, Roche focuses on areas including oncology, neurology, cardiovascular and metabolic diseases, ophthalmology, infectious diseases and immunology with the aim of providing real and positive change for patients, the people they love and the professionals who care for them.

Genentech in the United States is a fully owned subsidiary in the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.

For more information, please visit www.roche.com.

Bundibugyo virus Research Use Only test is for research use only. Not for use in diagnostic procedures.

All trademarks used or mentioned in this release are protected by law.

References

[1] CDC Ebola Outbreak: Current Situation. 07 September 2026: https://www.cdc.gov/ebola/situation-summary/index.html

[2] World Health Organization. Ebola disease caused by Bundibugyo virus – Democratic Republic of the Congo. Disease Outbreak News. 28 August 2026. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON616

[3] World Health Organization. Second meeting of the IHR Emergency Committee on the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo – Temporary recommendations. 24 August 2026. https://www.who.int/news/item/24-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo-temporary-recommendations

For further information, please contact

Katlego Ledimo, Africa Communications

Phone: +27 726 151 941  

e-Mail: [email protected] 

Kathryn Ager, Diagnostics Global Communications

Phone: +44 77 745 115 046

e-Mail: [email protected]

Share this article

Limestone Custom Homes Expands to Larimer County with New Luxury Build at TPC Colorado

One of Colorado's leading design-build custom home companies — with offices in Castle Rock and projects across Douglas County, Denver, and the Colorado mountains — brings its design-build model to Northern Colorado with an approximately 6,000-square-foot luxury home in the Heron Lakes at TPC Colorado community

BERTHOUD, Colo., Oct. 6, 2026 /PRNewswire/ -- Limestone Custom Homes, one of Colorado's leading design-build custom home companies, today announced its expansion into Larimer County with a new luxury home project in the Heron Lakes at TPC Colorado community in Berthoud. The approximately 6,000-square-foot residence marks Limestone's first build in Northern Colorado and extends a growing portfolio that already spans Douglas County, the Denver metro area, and the Colorado mountains.

Headquartered out of its Castle Rock offices, Limestone has built its reputation on a true design-build model — architecture, design, permitting, construction, and finish selections all handled under one roof by an in-house team. That integrated approach has made the company a trusted partner for Colorado homeowners seeking high-end custom builds without the fragmentation of coordinating multiple firms. As part of its Northern Colorado expansion, Limestone is also planning additional offices in the region to support local clients and ongoing projects.

The Heron Lakes at TPC Colorado community features a Tournament Players Club championship golf course and attracts buyers looking for luxury homes with resort-style amenities, Front Range views, and proximity to Rocky Mountain National Park. Larimer County — anchored by Fort Collins, Loveland, and Berthoud — continues to see strong demand for high-end custom homes as buyers relocate from across the country for the Northern Colorado lifestyle.

"Expanding into Larimer County is a natural next step for Limestone," a company spokesperson said. "We've built across Douglas County, Denver, and the mountains, and the demand we've seen from Northern Colorado buyers made it clear this market was ready for the kind of design-build experience we deliver. The Heron Lakes community at TPC Colorado is a strong first statement of what we bring to the region."

As a custom home builder in Larimer County, Limestone offers Northern Colorado homeowners direct access to its full in-house team of architects, designers, project managers, and craftsmen.

About Limestone Custom Homes

Limestone Custom Homes is one of Colorado's leading design-build custom home companies, with offices in Castle Rock, planned offices in Northern Colorado, and projects across Douglas County, the Denver metro area, the Colorado mountains, and now Larimer County. The company specializes in high-end custom homes with a fully in-house design, architecture, and construction team. For more information, visit Limestone Custom Homes.

Media Contact:

Limestone Custom Homes

Phone: (720) 477-7157

Website: https://limestonecustomhomes.com

SOURCE Limestone Custom Homes

Share this article

Simplicity AI SDK with new Simplicity Design Intelligence, open-source development, and Databricks initiatives help developers build faster and bring edge AI into enterprise workflows

AUSTIN, Texas, Oct. 7, 2026 /PRNewswire/ -- Works With Summit 2026 – Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless connectivity, today announced a set of developer initiatives that makes it easier to build, extend, and operate increasingly capable IoT devices. Unveiled at the company's seventh annual Works With Summit, the new offerings expand what developers and their AI agents can create on the Silicon Labs platform, while helping customers develop, deploy, and manage intelligence at the edge.

News at a Glance

- Design with AI: The Simplicity AI SDK is now in public Beta and supports AI coding assistants including GitHub Copilot, Cursor, and Codex. Silicon Labs is also introducing Simplicity Design Intelligence, a broad and growing set of capabilities designed to understand hardware and software intent, help customers turn that intent into a working product, and verify the implementation against the original intent. Hardware Intent is the first capability.

- Build and extend: The Silicon Labs open-source community is launching in Beta with Bluetooth® Low Energy (LE), giving developers access to sample applications and tooling and a direct way to raise issues, propose fixes, contribute code, and extend the Silicon Labs software platform.

- Scale edge intelligence: Silicon Labs' platform-agnostic edge AI and machine learning tools can now connect with Databricks, the data and AI company, so customers can manage data, models, embedded optimization, and hardware test results with governed enterprise data and AI workflows on the Databricks Data + AI platform.

Development Complexity Cannot Scale with IoT

As connected products add intelligence and custom hardware, building them grows more complex. Developers navigate specialized SDKs, configuration tools, debugging environments, and hardware constraints while using general-purpose AI assistants that do not inherently understand Silicon Labs devices or embedded workflows. Development teams also need better ways to share improvements and manage AI models as intelligence moves from the cloud onto edge devices. If workflows become harder with every new capability, development complexity becomes a barrier to scaling IoT.

"More capable silicon should not create more development complexity," said Manish Kothari, Senior Vice President of Software at Silicon Labs. "We are giving developers and their AI agents a connected path from hardware and software intent through implementation, community contribution, and the complete AI lifecycle."

Simplicity AI SDK and Simplicity Design Intelligence Connect Intent to Product

Simplicity AI SDK has entered public Beta, giving developers and their AI coding assistants structured access to Silicon Labs SDKs, tools, documentation, and connected hardware. Rather than requiring a proprietary AI assistant, the SDK works with tools developers may already use. GitHub Copilot, Cursor, and Codex are supported in the Beta. This grounding gives general-purpose AI assistants Silicon Labs-specific context. The first officially supported experience focuses on Bluetooth® Low Energy (LE), with workflows spanning project creation and configuration, building, flashing, debugging, network and power analysis, documentation search, and hardware interaction.

Simplicity Design Intelligence extends that foundation. It is a broad and growing set of Silicon Labs capabilities designed to understand hardware and software intent, help customers realize that intent in a working product, and verify the implementation against the original intent. Hardware Intent is the first capability. It uses product requirements, board schematics, and other input hardware documentation from datasheets to meeting notes to guide pin, peripheral, and software configuration, then compares the result with the original intent. This can find pin conflicts, peripheral mismatches, and missing constraints before fabrication and help reduce avoidable board respins.

"We've been working closely with Silicon Labs as an Alpha customer, evaluating how the Hardware Intent Agent can streamline hardware development across our current and future products while providing feedback on new features as it progresses towards general release," said Limor Alkelai, Co-CEO, at Risco Group. "We see its potential in enabling quicker and more robust development."

Collaborate, Build, and Extend Through the Open-Source Community

Drawing on its experience advancing open-source development for Matter, Thread, and Zephyr, Silicon Labs is launching its open-source developer community in Beta, beginning with Bluetooth LE. The mantra is simple: build and extend. Developers can build with Silicon Labs sample applications and tooling, then extend the platform by raising issues, suggesting fixes, and contributing through pull requests.

Accepted contributions can move through the company's normal engineering and testing processes into future SDK releases. Even before acceptance, proposed fixes and discussions can remain visible to other developers, giving the community another way to share knowledge and solve common problems. The Silicon Labs applications team will support issues raised on GitHub, and Silicon Labs plans to expand this approach to additional wireless technologies over time.

Scale the Complete Edge AI Lifecycle with Databricks

As edge AI grows, model development also needs to connect with the data and AI infrastructure enterprises already use. Silicon Labs is partnering with Databricks to bring embedded edge AI into Databricks, creating a unified, governed foundation for connecting edge devices with enterprise data, AI, and machine learning workflows.

An initial Silicon Labs MLOps SDK experience connects devices with Databricks to help capture data from the device fleet. Once the data is in Databricks, all the familiar MLOps tools and training pipelines and GPU resources are available directly for training. Once a model is trained, the Silicon Labs ML Profiler can provide directionally accurate feedback on whether a model fits target hardware and its memory and CPU requirements. That feedback can help ML engineers iterate while remaining in a familiar Databricks environment, connecting model development with the enterprise data and governance that underpin production AI. This approach helps enterprises extend AI from the cloud to the edge without creating separate data and AI stacks for embedded workloads.

A Platform that Developers Can Build and Extend

Together, these initiatives scale the development system at three levels:

- The Simplicity AI SDK and Simplicity Design Intelligence help developers and their AI agents move from hardware and software intent to a working product, with Hardware Intent as the first of a growing set of Design Intelligence capabilities.

- The open-source community gives developers a direct way to build and extend the platform.

- Silicon Labs edge AI tools and Databricks connect embedded AI development with enterprise data and AI governance. Silicon Labs intends to make increasingly capable silicon easier to use and earn the position of platform of choice for embedded wireless development.

Availability and Next Steps

The Simplicity AI SDK Beta is publicly available, with official support initially focused on Bluetooth LE and support for GitHub Copilot and Codex. An alpha release of Hardware Intent, the first capability in Simplicity Design Intelligence, is planned for January 2027.

The Silicon Labs open-source community Beta launches with Bluetooth LE, and its sample applications are accessible on GitHub for code review and contributions.

Initial Silicon Labs MLOps tools are available in Databricks today.

About Silicon Labs

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers with the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over sixteen countries and is the trusted partner for innovative solutions in smart home, industrial IoT, and smart cities markets. Learn more at https://www.silabs.com.

SOURCE Silicon Labs

Share this article

Strategic partnership modernizes how senior living operators capture real-time resident and family feedback.

WASHINGTON, Oct. 7, 2026 /PRNewswire/ -- U.S. News & World Report, the global authority in healthcare decision support, today announced a strategic partnership with and investment in Candid, an AI-powered engagement start-up serving senior living and post-acute care organizations, to modernize feedback collection and advance resident engagement and quality measurement standards across the senior living industry.

Through the partnership, U.S. News and Candid equip senior living communities to move beyond traditional static questionnaires through AI-powered, conversational engagement tools. The integration expands the tools available to operators to capture real-time insights from residents and their families, turning direct resident and family input into measurable quality improvements.

This collaboration comes at a pivotal time for the senior care sector. With 10,000 Americans reaching retirement age daily – known as "The Peak 65 Phenomenon" – the need for transparent, reliable data to guide family care decisions and evaluate community performance continues to grow. Building on U.S. News' 2026 Best Senior Living ratings, which evaluated communities based on feedback from more than 540,000 consumer surveys, U.S. News continues to lead efforts to standardize resident engagement measures and bring modern, data-driven capabilities to senior living operators and care providers.

"For five years, U.S. News' Best Senior Living ratings have provided families with trusted data and benchmarks as they evaluate their senior living options," said Sumita Singh, executive vice president and general manager of Health at U.S. News. "As millions of older adults enter retirement, improving how senior living communities capture resident and family feedback is a must. Our strategic partnership with Candid reflects our commitment to bringing frictionless technologies to senior living operators so they can gather real-time resident and family feedback across all modalities."

Candid's platform uses interactive voice and text conversations that allow residents, family members and employees to provide feedback in their own words. The platform combines quantitative metrics with qualitative sentiment analysis, identifying recurring themes, emerging operational concerns and trends.

Across current deployments – which span hundreds of senior living communities nationwide – Candid's conversational format averages an approximate 70 percent response rate, drastically outperforming traditional survey channels.

"Senior living organizations have historically had to choose between collecting structured data at scale and having meaningful conversations with residents, families, and employees," said Raphael Rubens, founder and CEO of Candid. "AI allows us to combine both, understand what is driving the feedback and turn those insights into action, ultimately improving the experience and quality of care for residents."

About U.S. News & World Report

U.S. News & World Report is the global leader for journalism that empowers consumers, citizens, business leaders and policy officials to make confident decisions in all aspects of their lives and communities. A multifaceted media company, U.S. News provides unbiased rankings, independent reporting and analysis, and consumer advice to millions of people on USNews.com each month. A pillar in Washington for more than 90 years, U.S. News is the trusted home for in-depth and exclusive insights on education, health, politics, the economy, insurance, personal finance, travel, automobiles, real estate, careers and consumer products and services.

About Candid

Candid Technology, Inc. ("Candid") is an AI powered engagement platform for senior living and post acute care. Its technology helps organizations collect resident, family, and employee feedback, improve online reputation, understand retention, and automate frontline applicant engagement and interviews. Candid has been deployed across hundreds of communities throughout the United States and is backed by leading investors. For more information, visit callcandid.com.

SOURCE U.S. News & World Report, L.P.

Share this article